EDGAR Filing Documents for 0001654954-17-003254

Form 8-K - Current report:

SEC Accession No. 0001654954-17-003254

Filing Date

2017-04-12

Accepted

2017-04-12 09:25:46

Documents

Period of Report

2017-04-11

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	azrx8k_arp112017.htm	8-K	27581
2	PRESS RELEASE	ex99-1.htm	EX-99.1	18619
	Complete submission text file	0001654954-17-003254.txt		47373

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226

Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855

AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 17757140
SIC: 2834 Pharmaceutical Preparations